Key points are not available for this paper at this time.
기 available therapies에 저항성인 리켄 플라누스(LP) 환자들은 종종 높은 질병 부담을 경험하며, 이는 새로운 치료법에 대한 분명한 충족되지 않은 필요가 있는 집단을 나타냅니다.
Building similarity graph...
Analyzing shared references across papers
Loading...
Thierry Passeron
Inserm
Maximilian Reinhardt
Novartis (Switzerland)
Benjamin D. Ehst
Oregon Medical Research Center
British Journal of Dermatology
Inserm
University of California, Davis
Friedrich-Alexander-Universität Erlangen-Nürnberg
Building similarity graph...
Analyzing shared references across papers
Loading...
Passeron et al. (Mon,) 이 질문을 연구했습니다.
synapsesocial.com/papers/68e6a4f8b6db64358762829d — DOI: https://doi.org/10.1093/bjd/ljae181
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: